A new platform combines AI, flow chemistry and robotics to minimise the need for human intervention in the synthesis process.
List view / Grid view
Filter the results
Marc Baiget-Francesch highlights interesting developments in the field of protein drug design and explains how continual software improvements are speeding up the process.
There is still much to be done regarding how training is delivered and monitored in core technologies such as flow cytometry. Here, Derek Davies outlines the approaches his team at The Francis Crick Institute are taking to train users of such technologies to ensure quality data is obtained and best…
As research moves forward at a rapid pace and data is being generated in larger quantities than ever before, one problem the scientific community faces is reproducibility.
As technology advances and scientific research progresses at a rapid pace, data is being generated in ever-larger quantities. Even with the forward strides in technology and advances in data processing, a common problem widely acknowledged by the scientific community is that of reproducibility. In this article, Matjaz Hren discusses the…
Whitepaper: Evaluating the impact of error rate on productivity and cost savings in synthetic DNA fragments
GeneArt High-Q Strings DNA Fragments versus other suppliers’ products.
Innovations in synthesis technology and gene synthesis have become a powerful and valuable means of obtaining genetic material.
It is predicted that there will be 70 new monoclonal antibody (mAb) biotherapeutics available by 2020.
The number of oligonucleotide-based platforms on the market is constantly increasing and has led to the emergence of innovative nucleic acid-based therapeutic modalities such as CRISPR-Cas, sgRNAs or mRNAs.
New lab on a chip technology has been developed to evaluate the effects of different drivers of NAFLD on liver cells.
New computer model that simulates the way red blood cells become misshapen by sickle cell disease could identity promising drug candidates.
Researchers hope the system can choose the right patients to enroll in clinical trials, to speed discovery of drug treatments.
A unique method for studying proteins has been developed which could open new doors for medicinal research.